Quarterly results

Q3 2026

Read Q3 2026 report

Philips delivers strong order intake growth, comparable sales growth and strong margin expansion in Q3; 2026 outlook reiterated

Q3 2026 at a glance

Key figures

Sales
4.4 billion EUR
Sales

Group sales in Q3 2026 amounted to EUR 4.4 billion.

Read more
Comparable sales growth
3%
Comparable sales growth

Comparable sales increased by 3%, driven by Personal Health and Connected Care.

Read more
Adjusted EBITA margin
13%
Adjusted EBITA margin

Adjusted EBITA was EUR 569 million and the margin improved to 13.0%.

Read more
Lives improved
2 billion
Lives improved

In Q3 2026, we improved the lives of 2 billion people.

Read more
Full value chain carbon emissions
917 kilotonnes CO₂-e
Full value chain carbon emissions

Our full value chain emissions measure our climate impact across our scope 1, 2 and material scope 3 emission categories.

Read more
Employees
~64,000
Employees

The total number of Philips employees (in full-time equivalents, excluding third-party workers) was 63,909 at the end of Q3 2026.

Read more

Customer and innovation highlights

The innovation that Philips brings to healthcare – often as part of long-term partnerships – is critical, making care delivery more convenient and sustainable.

Robotics and advanced imaging

Philips is accelerating innovation in image-guided therapy. In the Netherlands, Philips is investing EUR 50 million in AI, robotics and advanced imaging, alongside over EUR 100 million from the Dutch government and a further EUR 150 million in private financing by Invest-NL and institutional investors, including pension funds. In the US, an ARPA-H award of up to USD 34 million will support AI-enabled robotic stroke care on the Azurion platform.

Learn more

Connecting across healthcare settings

Ontario Health in Canada selected the Philips Enterprise Imaging Vendor Neutral Archive to modernize province-wide imaging infrastructure and connect patient information across care settings. This Vendor Neutral Archive will support the sharing of more than 20 million imaging studies annually across more than 150 hospitals and 50 imaging clinics, helping enable a holistic patient view and more timely access to care.

Innovations for personalized needs

Personal Health launched innovations across oral care, beauty and mother and child care. These include the AI-powered Sonicare DiamondClean 9900 Prestige, the first at-home IPL with real-time guidance Lumea 9900 Pro, and Philips Avent’s first fully wearable Natural Care breast pump, bringing more personalized and premium solutions to consumers.

Access to care around the world

Philips Foundation has awarded its 2026 Social Impact Award to Muso, recognizing its Rapid Care model for improving access to quality healthcare for women and children in underserved communities in West Africa.

Learn more
Our Impact Ambitions

Driving equitable and sustainable healthcare

At Philips, we are partnering with our stakeholders to drive environmental, social and governance priorities and make a global impact.

Download full overview
Downloads

Q3 results

Q3 2026 report
831 KB
Q3 2026 results presentation
1 MB
Q3 2026 webcast